calendar
5,599 catalysts · 5,256 phase readout · 2,298 8k filing · 343 pdufa · 255 earnings · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
5,599 catalysts · 5,256 phase readout · 2,298 8k filing · 343 pdufa · 255 earnings · 2 approval · 1 adcom
Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Colorectal Polyps
Sponsor: National Institute on Aging (NIA). Phase: . Conditions: Neurogimaging
Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: AML, Adult, Minimal Residual Disease
Sponsor: University Hospital, Montpellier. Phase: . Conditions: Systemic Sclerosis
Sponsor: Biomed Industries, Inc.. Phase: PHASE3. Conditions: Rett Syndrome
Sponsor: King's College London. Phase: . Conditions: Eczema, Atopic Dermatitis, Atopic Eczema
Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Overweight and Obesity
Sponsor: University of Chicago. Phase: PHASE1. Conditions: Tibial Plateau Fractures
Sponsor: OncoVerity, Inc.. Phase: PHASE2. Conditions: Leukemia, Myeloid, Acute
Sponsor: BrainCheck, Inc.. Phase: . Conditions: Cognitive Change, Cognitive Decline, Cognitive Deterioration, Neurocognitive Deficit
Sponsor: Ascentage Pharma Group Inc.. Phase: PHASE1. Conditions: Platinum-resistant Recurrent Ovarian Cancer, Advanced Solid Tumor
Sponsor: University of Kansas Medical Center. Phase: PHASE3. Conditions: Inclusion Body Myositis
Sponsor: University of Edinburgh. Phase: PHASE2. Conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Sponsor: Franziska Wachter. Phase: PHASE2. Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloid Malignancies, MDS, Inherited Bone Marrow Failure Syndrome, Myeloid Neoplasm, Aml
Sponsor: Mayo Clinic. Phase: NA. Conditions: Gastroparesis
Sponsor: University of Milano Bicocca. Phase: . Conditions: Mild Cognitive Impairment, Subjective Cognitive Decline
Sponsor: Khyber Teaching Hospital. Phase: NA. Conditions: Labor and Delivery
Sponsor: Pfizer. Phase: . Conditions: Transthyretin Amyloid Cardiopathy
Sponsor: Manisa Celal Bayar University. Phase: NA. Conditions: Healthy, Stress, Exercise
Sponsor: Mario Negri Institute for Pharmacological Research. Phase: . Conditions: Chronic Kidney Disease (Stages 4 and 5)
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE2. Conditions: Moderate to Severe Active Rheumatoid Arthritis
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE2. Conditions: Soft Tissue Sarcoma
Sponsor: University of Washington. Phase: NA. Conditions: Neurodevelopment, Child Growth
Sponsor: PreludeDx. Phase: . Conditions: DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Sponsor: University of Pittsburgh. Phase: . Conditions: Ischemic Stroke, Cryptogenic, Ischemic Stroke, Embolic, Hemorrhagic Stroke, Embolic Stroke of Undetermined Source, Recurrent Ischemic Stroke
Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Very Rare Tumors, Very Rare Cancers, Other Solid Tumors, Solid Tumor, Pediatric Rare Tumors
Sponsor: University of California, Davis. Phase: PHASE1. Conditions: Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer
Sponsor: Assuta Medical Center. Phase: . Conditions: Pressure Ulcer, Pressure Ulcer Prevention, Venous Thrombosis Deep (Limbs)
Sponsor: FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE. Phase: . Conditions: Human Immunodeficiency Virus Infection (HIV), HIV-1 Infection in Adults
Sponsor: Centro Integral Kaplan. Phase: NA. Conditions: Pediatric Hemiparesis
Sponsor: Harbin Medical University. Phase: NA. Conditions: Autism Spectrum Disorder
Sponsor: University of Utah. Phase: NA. Conditions: Malignant Ascites
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma
Sponsor: University of California, Los Angeles. Phase: PHASE2. Conditions: Memory, Cognitive Function Decline
Sponsor: University Tunis El Manar. Phase: NA. Conditions: System; Lupus Erythematosus
Sponsor: Guangzhou University of Traditional Chinese Medicine. Phase: PHASE2. Conditions: Advanced Non-small Cell Lung Cancer (NSCLC), EGFR Exon 19 Deletion Mutation, EGFR Exon 21 Mutation, EGFR Exon 21 L858R Mutation
Sponsor: USWM CT, LLC. Phase: PHASE1. Conditions: Neoplasms
Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE2. Conditions: Heart Failure With Reduced Ejection Fraction, Hypotension, LV Dysfunction
Sponsor: Haseki Training and Research Hospital. Phase: PHASE4. Conditions: Cesarean Birth, Spinal Anesthesia, Sedation
Sponsor: Genentech, Inc.. Phase: PHASE4. Conditions: Multiple Sclerosis, Relapsing
Sponsor: University College London Hospitals. Phase: NA. Conditions: Obsessive - Compulsive Disorder, Tic Disorder, Chronic Motor or Vocal, Tic Disorders, Tic Disorder, Combined Vocal and Multiple Motor, Tourette Disease, Tourette Disorder, Tourettes Syndrome, Gilles de la Tourette Syndrome
Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Pre-Exposure Prophylaxis
Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE2. Conditions: Bipolar Disorder II
Sponsor: Wake Forest University Health Sciences. Phase: PHASE2. Conditions: Female Breast Carcinoma, Breast Cancer
Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Moderately to Severely Active Ulcerative Colitis
Sponsor: The Second Hospital of Anhui Medical University. Phase: NA. Conditions: Temporal Interference Stimulation, Non Suicidal Self Injury, Major Depressive Disorder
Sponsor: National University Health System, Singapore. Phase: NA. Conditions: Education, AI (Artificial Intelligence)
Sponsor: Fondazione Oncotech. Phase: . Conditions: Breast Cancer
Sponsor: Kite, A Gilead Company. Phase: PHASE1. Conditions: Lymphomas Non-Hodgkin's B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia